News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
307,968 Results
Type
Article (15329)
Company Profile (283)
Press Release (292356)
Section
Business (91507)
Career Advice (161)
Deals (16164)
Drug Delivery (35)
Drug Development (53658)
Employer Resources (31)
FDA (6847)
Job Trends (5536)
News (165012)
Policy (12311)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (955)
Accelerated approval (2)
Adcomms (12)
Allergies (53)
Alliances (26062)
ALS (61)
Alzheimer's disease (887)
Antibody-drug conjugate (ADC) (89)
Approvals (6878)
Artificial intelligence (118)
Autoimmune disease (13)
Automation (5)
Bankruptcy (110)
Best Places to Work (4797)
BIOSECURE Act (5)
Biosimilars (49)
Biotechnology (235)
Bladder cancer (47)
Brain cancer (20)
Breast cancer (153)
Cancer (1382)
Cardiovascular disease (113)
Career advice (140)
Career pathing (2)
CAR-T (107)
Cell therapy (314)
Cervical cancer (8)
Clinical research (43695)
Collaboration (526)
Compensation (231)
Complete response letters (13)
COVID-19 (1118)
CRISPR (37)
C-suite (152)
Cystic fibrosis (76)
Data (1428)
Denatured (11)
Depression (30)
Diabetes (131)
Diagnostics (1735)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (81)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (84)
Earnings (34084)
Editorial (17)
Employer branding (4)
Employer resources (29)
Events (52092)
Executive appointments (429)
FDA (7534)
Featured Employer (31)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (491)
Gene editing (89)
Generative AI (9)
Gene therapy (244)
GLP-1 (380)
Government (1195)
Grass and pollen (3)
Guidances (21)
Healthcare (7131)
Huntington's disease (21)
IgA nephropathy (22)
Immunology and inflammation (81)
Indications (19)
Infectious disease (1184)
Inflammatory bowel disease (115)
Inflation Reduction Act (8)
Influenza (23)
Intellectual property (64)
Interviews (17)
IPO (8102)
IRA (11)
Job creations (1042)
Job search strategy (135)
Kidney cancer (6)
Labor market (4)
Layoffs (207)
Leadership (2)
Legal (2134)
Liver cancer (39)
Lung cancer (198)
Lymphoma (88)
Machine learning (1)
Management (7)
Manufacturing (130)
MASH (52)
Medical device (3518)
Medtech (3520)
Mergers & acquisitions (8402)
Metabolic disorders (380)
Multiple sclerosis (54)
NASH (13)
Neurodegenerative disease (62)
Neuropsychiatric disorders (23)
Neuroscience (1271)
NextGen: Class of 2025 (2139)
Non-profit (891)
Northern California (1602)
Now hiring (21)
Obesity (192)
Opinion (100)
Ovarian cancer (60)
Pain (43)
Pancreatic cancer (56)
Parkinson's disease (111)
Partnered (9)
Patents (117)
Patient recruitment (68)
Peanut (35)
People (28078)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (15097)
Phase II (20134)
Phase III (13157)
Pipeline (777)
Podcasts (47)
Policy (38)
Postmarket research (991)
Preclinical (6298)
Press Release (32)
Prostate cancer (57)
Psychedelics (35)
Radiopharmaceuticals (220)
Rare diseases (283)
Real estate (1869)
Recruiting (12)
Regulatory (10076)
Reports (18)
Research institute (980)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (4)
RSV (10)
Schizophrenia (57)
Series A (95)
Series B (62)
Service/supplier (1)
Sickle cell disease (40)
Southern California (1426)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (11)
Startups (2176)
State (1)
Stomach cancer (5)
Supply chain (19)
Tariffs (3)
The Weekly (35)
United States (12693)
Vaccines (220)
Venture capitalists (29)
Webinars (7)
Weight loss (105)
Women's health (15)
Worklife (2)
Date
Today (65)
Last 7 days (480)
Last 30 days (1725)
Last 365 days (21179)
2025 (5180)
2024 (21860)
2023 (23973)
2022 (30256)
2021 (31144)
2020 (26603)
2019 (18342)
2018 (13442)
2017 (15640)
2016 (13742)
2015 (16812)
2014 (12453)
2013 (9312)
2012 (9526)
2011 (9709)
2010 (9315)
Location
Africa (195)
Alabama (38)
Alaska (2)
Arizona (59)
Arkansas (5)
Asia (30053)
Australia (4373)
California (3649)
Canada (1139)
China (372)
Colorado (138)
Connecticut (145)
Delaware (89)
Europe (44490)
Florida (431)
Georgia (112)
Idaho (16)
Illinois (220)
India (13)
Indiana (86)
Iowa (1)
Japan (114)
Kansas (63)
Kentucky (5)
Louisiana (3)
Maine (13)
Maryland (480)
Massachusetts (2920)
Michigan (70)
Minnesota (159)
Mississippi (1)
Missouri (25)
Montana (14)
Nebraska (4)
Nevada (16)
New Hampshire (14)
New Jersey (960)
New Mexico (12)
New York (1005)
North Carolina (540)
North Dakota (4)
Northern California (1602)
Ohio (108)
Oklahoma (9)
Oregon (22)
Pennsylvania (694)
Puerto Rico (3)
Rhode Island (15)
South America (273)
South Carolina (4)
Southern California (1426)
Tennessee (25)
Texas (416)
Utah (57)
Virginia (70)
Washington D.C. (29)
Washington State (325)
Wisconsin (17)
307,968 Results for "carrick therapeutics ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Carrick Therapeutics Establishes New Headquarters in Boston, Massachusetts and Appoints David Sutherland, CPA, as Vice President of Finance and Controller
Carrick Therapeutics Inc. today announced the relocation of its corporate headquarters from Dublin, Ireland to Boston, Massachusetts.
June 5, 2024
·
2 min read
Press Releases
Tenpoint Therapeutics Ltd. to Participate in Upcoming Investor Conferences in April
April 1, 2025
·
2 min read
Drug Development
Carrick Therapeutics Announces First Patient Dosed in Phase 1b/2 Clinical Trial of Samuraciclib in Combination with Vepdegestrant in Patients with Advanced Breast Cancer
Carrick Therapeutics today announced that the first patient has been dosed in its Phase 1b/2 clinical trial evaluating the combination of samuraciclib (CT7001).
February 14, 2024
·
4 min read
Press Releases
Carrick Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT7439 (CDK12/13 Inhibitor)
September 23, 2024
·
2 min read
Drug Development
Carrick Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Samuraciclib in Combination with Elacestrant in Patients with Advanced Breast Cancer
Carrick Therapeutics today announced that the first patient has been dosed in its Phase 2 clinical trial evaluating the novel combination of Carrick’s samuraciclib (CT7001).
October 18, 2023
·
6 min read
Press Releases
Tenpoint Therapeutics Ltd. Appoints Carol Kearney as Chief Commercial Officer
March 11, 2025
·
3 min read
Press Releases
Relmada Therapeutics Licenses Phase 2 Bladder Cancer Candidate, NDV-01, from Trigone Pharma, Ltd.
March 26, 2025
·
10 min read
Business
Carrick Therapeutics Announces Clinical Trial Collaboration with Arvinas and Pfizer to Evaluate Samuraciclib and Vepdegestrant Combination
Carrick Therapeutics today announced a clinical trial collaboration and supply agreement with Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE).
July 6, 2023
·
5 min read
Drug Development
Carrick Therapeutics Announces First Patient Dosed in Phase 2b Clinical Trial of Samuraciclib in Combination with Fulvestrant in Patients with Advanced HR+, HER2- Breast Cancer
Carrick Therapeutics today announced that the first patient has been dosed in its Phase 2b clinical trial evaluating the combination of samuraciclib (CT7001), an oral and first-in-class inhibitor of CDK7, and fulvestrant, an intramuscular injected selective estrogen receptor degrader (SERD), in women with HR+, HER2- advanced breast cancer previously treated with a CDK4/6 inhibitor.
December 15, 2023
·
3 min read
Genetown
Carrick Therapeutics Announces U.S. FDA Clearance of IND for CT7439, a First-In-Class Inhibitor of CDK12/13
Carrick Therapeutics, an oncology-focused biopharmaceutical company discovering and developing highly differentiated therapies, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for CT7439, a novel cyclin dependent kinase 12/13 (CDK12/13) inhibitor.
September 7, 2023
·
2 min read
1 of 30,797
Next
